Rating Change
Benchmark reiterated its Speculative Buy rating on Unicycive Therapeutics, Inc. (NASDAQ:UNCY) on August 20, 2026.
reiterateNASDAQ:UNCY
Benchmark Reiterates Speculative Buy Rating on Unicycive Therapeutics, Inc. (UNCY)
Benchmark reiterated its Speculative Buy rating on Unicycive Therapeutics, Inc. (NASDAQ:UNCY) on August 20, 2026.
At publication ·
What changed
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) · reiterate
- Firm
- Benchmark
- Rating
- Speculative Buy to Speculative Buy
- Price at event
- $5.45
- Market capitalization
- $113.3M
At a glance
Key takeaways
- Benchmark reiterated a Speculative Buy rating on Unicycive Therapeutics (UNCY) on August 20, 2026, with the stock trading at $5.45 and a market capitalization of $113.3 million.
Market Context
Unicycive Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $5.45 with a market capitalization of $113.3M.
Analyst coverage from Benchmark provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Unicycive Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Unicycive Therapeutics, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | Benchmark | Speculative Buy | N/A |
| Aug 13, 2026 | Guggenheim | Buy | N/A |
| Aug 13, 2026 | B. Riley Securities | Buy | N/A |
| Jul 01, 2026 | Benchmark | Speculative Buy | N/A |
| Jul 01, 2026 | Noble Capital Markets | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View UNCY Stock Page
Frequently Asked Questions
What does the Speculative Buy rating mean for UNCY?
A rating of Speculative Buy from Benchmark reflects the analyst's outlook on Unicycive Therapeutics, Inc. (NASDAQ:UNCY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the UNCY forecast page.